Nov 06, 2024 / 09:30PM GMT
Operator
Good afternoon and welcome to Cytokinetics third quarter, 2024 conference call. At this time, I would like to inform you that this call is being recorded and that all participants are in a listen-only mode at the company's request. We will open the call to questions after the presentation. We will allow for only one question per participant.
I will now turn the call over to Diane Weiser, Cytokinetics, Senior Vice President of Corporate Affairs. Please go ahead.
Diane Weiser - Cytokinetics Inc - Senior Vice President, Corporate Affairs
Good afternoon and thanks for joining us on the call today. Robert Blum, President and Chief Executive Officer will begin with an overview of the quarter and recent developments. Patty Malik EVP of R&D will provide updates related to the clinical development program for Aamp Andrew Callos EVP and Chief Commercial Officer will address commercial readiness activities for Aamp Stuart Kupfer as VP and Chief Medical Officer will provide updates regarding the Campton Macar Bill CK 586 and our earlier stage development
Q3 2024 Cytokinetics Inc Earnings Call Transcript
6 days ago
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers